While the FDA is facing a disrupted and uncharted future, drug development offers a few certainties, including that oncology and neuroscience still dominate the novel agents seeking approval. But the
In Vitro Diagnostics Mergers & Acquisitions Affymetrix Inc. eBioscience Inc. Genetic analysis company Affymetrix Inc. has signed a definitive agreement to buy private eBioscience Inc. (oncolog